These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 36206129)
1. MiR-30a-5p/CHD1 axis enhances cisplatin sensitivity of ovarian cancer cells via inactivating the Wnt/β-catenin pathway. Wang X; Zhao H; Wang P; Zhang J; Li N; Liu Y; Zhang F; Yu Y Anticancer Drugs; 2022 Nov; 33(10):989-998. PubMed ID: 36206129 [TBL] [Abstract][Full Text] [Related]
2. miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2. Song Z; Liao C; Yao L; Xu X; Shen X; Tian S; Wang S; Xing F Cancer Gene Ther; 2023 Apr; 30(4):596-607. PubMed ID: 36494581 [TBL] [Abstract][Full Text] [Related]
3. A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells. Han X; Zhen S; Ye Z; Lu J; Wang L; Li P; Li J; Zheng X; Li H; Chen W; Li X; Zhao L Cell Physiol Biochem; 2017; 41(3):973-986. PubMed ID: 28222434 [TBL] [Abstract][Full Text] [Related]
4. MiR-30a-5p Enhances Cisplatin Sensitivity by Downregulating RIF1 in Ovarian Cancer. Yao W; Wang Y; Huang M; Zhou J; Zheng R; Jin C; Zhang Y Ann Clin Lab Sci; 2023 May; 53(3):418-426. PubMed ID: 37437929 [TBL] [Abstract][Full Text] [Related]
5. DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP. Liu R; Zhang Y; Sun P; Wang C Open Biol; 2020 Apr; 10(4):190173. PubMed ID: 32343928 [TBL] [Abstract][Full Text] [Related]
6. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells. Yao W; Guo P; Mu Q; Wang Y Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541 [No Abstract] [Full Text] [Related]
7. MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy. Cai Y; An B; Yao D; Zhou H; Zhu J Bioengineered; 2021 Dec; 12(2):10713-10722. PubMed ID: 34747309 [TBL] [Abstract][Full Text] [Related]
8. SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling. Fu Q; Sun Z; Yang F; Mao T; Gao Y; Wang H Cell Mol Biol Lett; 2019; 24():71. PubMed ID: 31889959 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway. Zhang Y; Li Y Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway. Dai J; Wei R; Zhang P; Kong B J Transl Med; 2019 Jun; 17(1):190. PubMed ID: 31171023 [TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling. Ma J; Zhao D; Yu D; Song W; Yang X; Yin H Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781 [TBL] [Abstract][Full Text] [Related]
12. Effect and mechanism of miR-217 on drug resistance, invasion and metastasis of ovarian cancer cells through a regulatory axis of CUL4B gene silencing/inhibited Wnt/β-catenin signaling pathway activation. Liu HR; Zhao J Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):94-107. PubMed ID: 33506897 [TBL] [Abstract][Full Text] [Related]
13. CircRASSF2 facilitates the proliferation and metastasis of colorectal cancer by mediating the activity of Wnt/β-catenin signaling pathway by regulating the miR-195-5p/FZD4 axis. Yang L; Bi T; Zhou S; Lan Y; Zhang R Anticancer Drugs; 2021 Oct; 32(9):919-929. PubMed ID: 33929991 [TBL] [Abstract][Full Text] [Related]
14. circFBXO7/miR-96-5p/MTSS1 axis is an important regulator in the Wnt signaling pathway in ovarian cancer. Wu M; Qiu Q; Zhou Q; Li J; Yang J; Zheng C; Luo A; Li X; Zhang H; Cheng X; Lu W; Liu P; Lu B; Lu Y Mol Cancer; 2022 Jun; 21(1):137. PubMed ID: 35768865 [TBL] [Abstract][Full Text] [Related]
15. miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway. Liu S; Wang Q; Liu Y; Xia ZY J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502580 [TBL] [Abstract][Full Text] [Related]
16. MiR-449b-5p inhibits human glioblastoma cell proliferation by inactivating WNT2B/Wnt/β-catenin signaling pathway. Hou WZ; Chen XL; Qin LS; Xu ZJ; Liao GM; Chen D; Hu LJ; Mao ZM; -S Huang J; Yuan Q; Liao C; Yao QM Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5549-5557. PubMed ID: 32495889 [TBL] [Abstract][Full Text] [Related]
17. MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B. Niu Q; Liu Z; Gao J; Wang Q Yonsei Med J; 2019 Dec; 60(12):1146-1156. PubMed ID: 31769245 [TBL] [Abstract][Full Text] [Related]
18. The effects of miR-140-5p on the biological characteristics of ovarian cancer cells through the Wnt signaling pathway. Wu Y; Li J; Chen S; Yu Z Adv Clin Exp Med; 2020 Jul; 29(7):777-784. PubMed ID: 32750755 [TBL] [Abstract][Full Text] [Related]
19. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes. Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456 [TBL] [Abstract][Full Text] [Related]
20. MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3. Wei W; Yang Y; Cai J; Cui K; Li RX; Wang H; Shang X; Wei D Cell Physiol Biochem; 2016; 39(3):1165-76. PubMed ID: 27576787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]